Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited (TEVA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TEVA · as of Jun 8, 2026
Key Statistics
Explore Teva Pharmaceutical Industries Limited Data
teva stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 46 · Buy rate: 47.8%
The TEVA analyst consensus is Buy, based on ratings from 46 Wall Street analysts over the past 3 months. The average 12-month price target is $39.29, representing +14.92% upside from the current price of $34.19.
Competitors & Peers
teva competitorsTEVA
BIIB
BNTX
DXCM
LH
NBIXStock Performance
Full HistoryAbout Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North Ameri…
what is teva pharmaceutical industries limited · teva stock overview · teva pharmaceutical industries limited company profile · who is teva pharmaceutical industries limited ceo · teva NYSE · teva pharmaceutical industries limited headquarters · teva pharmaceutical industries limited business segments
About Stock Overview & Key Data
Teva Pharmaceutical Industries Limited (TEVA) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NYSE since Feb 16, 1982. As of the latest trading session, TEVA stock price is $34.19, with a market capitalization of $39.8B. The stock has returned +89.21% over the past 12 months and +9.55% year-to-date.
According to 46 Wall Street analysts, the consensus rating for Teva Pharmaceutical Industries Limited stock is Buy, with an average 12-month price target of $39.29. In fiscal year 2025, Teva Pharmaceutical Industries Limited reported revenue of $17.3B and net income of $1.4B. For detailed data — including Teva Pharmaceutical Industries Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Teva Pharmaceutical Industries Limited (TEVA) stock price is $34.19. The stock is traded on NYSE under the ticker symbol TEVA. The 52-week range is $14.99 – $37.35.